An analysis of tumor progression kinetics demonstrated that anti-CTLA4 mAb treatment reduced the tumor volume in NS (Figure 2D) and LS (Figure 2F) diet cohorts, as compared to respective isotype controls. The gene discussed is CTLA4; the disease is neoplasm.